Angiotension II Receptor Antagonists

From the synopsis: "The recent development of several new, non‑peptide, orally active angiotensin II receptor antagonists is revolutionizing the treatment of patients with hypertension and various cardiovascular disorders. In this book, experts review the current state of angiotensin II antagonists and survey the progress of these diverse applications. Issues relating to angiotensin II and th…